Phase II study of weekly carboplatin in pretreated adult malignant gliomas.

Veronica VillaniAndrea PaceAntonello VidiriAntonio TanzilliFrancesca SperatiIrene TerrenatoCarosi MariantoniaBeatrice CasiniGiulio MetroMarta MaschioKoudriavtseva TatianaFrancesco CognettiAlessandra Fabi

Published in: Journal of neuro-oncology (2019)

Our findings show that single agent, weekly, intravenous administration of carboplatin may have a role in patients with recurrent glioma and suggest that pre-treatment with corticosteroids may confer survival benefit.

Keyphrases

phase ii study
open label
locally advanced
high grade
placebo controlled
high dose
squamous cell carcinoma
clinical trial
randomized controlled trial
combination therapy
childhood cancer
free survival
study protocol
smoking cessation
replacement therapy